Comparative Effectiveness Comparative Effectiveness and H.R. 1 American Recovery and Reinvestment Act of 2009. Monitor federal related to Medicare and other healthcare issues.

Budget resolution FY2010, Pathway for Biosimilars Act (H.R. 1548).  Health Care Reform Legislation.  Pharmaceutical import safety legislation. Comparative Effectiveness.  Monitor federal related to Medicare and other healthcare issues.  In addition, Patent Reform Act of 2009 (H.R. 1260/S. 515/S. 610).  Budget resolution FY2010, Pathway for Biosimilars Act (H.R. 1548).  Health Care Reform Legislation.  Pharmaceutical import safety legislation.  Health legislation. Issues regarding follow on bologics, H.R. 5629 Pathway for Biosimilar Act; S. 1695 Biologics, Price Competition and Innovation Act of 2007, H.R. 1956 - provide for approval of similar biological products, H.R. 5629 - establish a pathway for the licensure of biosimilar biological products, H.R. 1038 - provide for licensing of comparable and interchangable biological products, H.R. 3200, S. 1679.
MED - Medical/Disease Research/Clinical Labs BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RYAN MACKINNON VASAPOLI AND BERZOK, LLP
1634 I Street, NW Suite 1200, Washington, DC, 20006, US
THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS